Novavax Inc. has officially started a late-stage clinical trial for its seasonal flu vaccine, a critical phase for the Gaithersburg biotech vying for a much-needed win this time around. The company is launching the phase 3 study for NanoFlu, its seasonal influenza candidate, after several devastating disappointments this year, starting with a failed late-stage trial for ResVax, its RSV vaccine for newborns given through maternal immunization. That news had battered the company with a tanking stock,…
from https://www.bizjournals.com/baltimore/news/2019/10/15/novavax-kicks-off-late-stage-trial-for-new.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/188364993492
No comments:
Post a Comment